Bladder Cancer

Investigation and management of bladder cancer.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
UrologyOncology

Clinical Guidelines

Bladder Cancer: ESMO Clinical Practice Guidelines
National
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
National
EAU Guidelines on Non-muscle-invasive Bladder Cancer
National
NICE guideline [NG12]: Suspected cancer: recognition and referral
National
NICE guideline [NG2]: Bladder Cancer
National
NICE guideline [NG2]: Bladder cancer: diagnosis and management
National
Bladder Cancer Treatment (PDQ®) – Health Professional Version
Local
Bladder Cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Local
Bladder Cancer: Non-Muscle Invasive Guideline - American Urological Association (AUA)
Local
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment
Local
EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer
Local
EAU Guidelines on Non-Muscle-Invasive Bladder Cancer
Local
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer
Local
ESMO Clinical Practice Guideline: Bladder Cancer
Local
ESMO Consensus Recommendations: Bladder Cancer
Local
FDA Guidance: Bacillus Calmette-Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs and Biologics for Treatment
Local
Guideline on Muscle-Invasive and Metastatic Bladder Cancer: American Society of Clinical Oncology (ASCO) Endorsement of the EAU Guideline
Local
NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer
Local
NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer. Version: 2.2025
Local
NICE Guideline, No. 2: Bladder Cancer. Diagnosis and Management
Local
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer (AUA/ASCO/ASTRO/SUO Guideline)
Local